轻缺血性卒中3种不同恢复表型的全基因组关联研究
在维生素干预卒中预防队列中,纳入1270例随机化时NIHSS>0且无复发卒中的基因分型患者,用NIHSS子评分定义认知、运动和全局恢复表型,对2年评分变化进行GWAS分析,发现多个提示性基因-损伤关联。
要点
- 认知、运动和全局损伤2年恢复表型分别识别出提示性基因关联。
- 随机化时20%有认知缺损、70%有≥1项运动缺损,2年时分别降至7.2%和30%。
- 使用领域特异性恢复表型和纵向设计有助于发现与慢性恢复相关的新基因。
核心结论
- 定义领域特异性卒中恢复表型并结合纵向临床试验设计,有助于检测与慢性恢复相关的新基因。
- 数据支持使用细粒度终点来识别与卒中恢复相关的遗传关联。
研究设计与样本
- 在维生素干预卒中预防队列中,纳入随机化时总NIHSS评分大于0且试验期间无复发卒中的基因分型参与者。
- 共纳入1270例参与者(64%男性),中位NIHSS评分2分(IQR 1-3),中位年龄68岁(IQR 59-75)。
- 使用特定测量估计2年内认知、运动和全局损伤的变化,采用GWAS线性混合效应模型预测评分变化,参与者作为随机效应,并纳入初始评分、年龄、性别、治疗组和前5个祖先主成分。
主要发现
- 随机化时20%有认知缺损(NIHSS Cog-4评分>0),70%有≥1项运动缺损(损伤评分>1)。
- 2年时,有认知缺损者降至7.2%,有运动缺损者降至30%。
- GWAS识别出提示性基因-损伤关联(p < 5e-6):认知(CAMK2D、EVX2、LINC0143、PTPRM、SGMS1和SMAD2)、运动(ACBD6、KDM4B、MARK4、PTPRS、ROBO1和ROBO2)和全局(MSR1和ROBO2)损伤。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Stroke genetic research has made substantial progress in the past decade. Its recovery application, however, remains behind, in part due to its reliance on the modified Rankin Scale (mRS) score as a measure of poststroke outcome. The mRS does not map well to biological processes because numerous psychosocial factors drive much of what the mRS captures. Second, the mRS contains multiple disparate biological events into a single measure further limiting its use for biological discovery. This led us to investigate the effect of distinct stroke recovery phenotypes on genetic variation associations with Genome-Wide Association Studies (GWASs) by repurposing the NIH Stroke Scale (NIHSS) and its subscores. METHODS: In the Vitamin Intervention for Stroke Prevention cohort, we estimated changes in cognition, motor, and global impairments over 2 years using specific measures. We included genotyped participants with a total NIHSS score greater than zero at randomization and excluded those with recurrent stroke during the trial. A GWAS linear mixed-effects model predicted score changes, with participant as a random effect, and included initial score, age, sex, treatment group, and the first 5 ancestry principal components. RESULTS: In total, 1,270 participants (64% male) were included with a median NIHSS score of 2 (interquartile range [IQR] 1-3) and median age 68 (IQR 59-75) years. At randomization, 20% had cognitive deficits (NIHSS Cog-4 score >0) and 70% had ≥1 motor deficits (impairment score >1). At 2 years, these percentages improved to 7.2% with cognitive deficits and 30% with motor deficits. GWAS identified novel suggestive gene-impairment associations (p < 5e-6) for cognition (CAMK2D, EVX2, LINC0143, PTPRM, SGMS1, and SMAD2), motor (ACBD6, KDM4B, MARK4, PTPRS, ROBO1, and ROBO2), and global (MSR1 and ROBO2) impairments. DISCUSSION: Defining domain-specific stroke recovery phenotypes and using longitudinal clinical trial designs can help detect novel genes associated with chronic recovery. These data support the use of granular endpoints to identify genetic associations related to stroke recovery.
引用
- Aldridge CM, Braun R, Lohse K, et al. Genome-Wide Association Studies of 3 Distinct Recovery Phenotypes in Mild Ischemic Stroke. Neurology. 2024. PMID: 38181310. doi:10.1212/WNL.0000000000208011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。